PTCT Q2 2017 Earnings — PTC Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

PTCTPTC Therapeutics, Inc.

$5B

Q2 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$48M+206.8% YoY

Gross Profit

$47M98.4% margin

Operating Income

-$12M-26.1% margin

Net Income

-$17M-36.4% margin

EPS (Diluted)

$-0.44

QoQ Revenue Growth

+80.7%

Cash Flow

Operating Cash Flow

$13M

Free Cash Flow

$13M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$383M

Total Liabilities

$213M

Stockholders' Equity

$170M

Cash & Equivalents

$181M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$16M	+206.8%
Gross Profit	$47M	-$13M	+457.8%
Operating Income	-$12M	-$37M	+65.8%
Net Income	-$17M	-$39M	+55.1%